Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/10230/25436
dc.contributor.author | Sanz Pamplona, Rebeca |
---|---|
dc.contributor.author | Aragüés Peleato, Ramón |
dc.contributor.author | Driouch, Keltouma |
dc.contributor.author | Martín, Berta |
dc.contributor.author | Oliva Miguel, Baldomero |
dc.contributor.author | Gil, Miguel |
dc.contributor.author | Boluda, Susana |
dc.contributor.author | Fernández, Pedro L. |
dc.contributor.author | Martínez, Antonio |
dc.contributor.author | Moreno, Víctor |
dc.contributor.author | Acebes, Juan J. |
dc.contributor.author | Lidereau, Rosette |
dc.contributor.author | Reyal, Fabien |
dc.contributor.author | Van de Vijver, Marc J. |
dc.contributor.author | Sierra, Angels |
dc.date | 2011 |
dc.identifier.citation | Sanz-Pamplona R, Aragüés R, Driouch K, Martín B, Oliva B, Gil M et al. Expression of endoplasmic reticulum stress proteins is a candidate marker of brain metastasis in both ErbB-2+ and ErbB-2- primary breast tumors. American journal of pathology. 2011. 179(2): 564-579. DOI 10.1016/j.ajpath.2011.04.037 |
dc.identifier.citation | 0002-9440 |
dc.identifier.citation | http://dx.doi.org/10.1016/j.ajpath.2011.04.037 |
dc.identifier.uri | http://hdl.handle.net/10230/25436 |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation | American journal of pathology. 2011. 179(2): 564-579 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | © Elsevier This is the published version of an article http://dx.doi.org/10.1016/j.ajpath.2011.04.037 that appeared in the journal American journal of pathology. It is published in an Open Archive under an Elsevier user license. Details of this licence are available here: http://www.elsevier.com/about/open-access/open-access-policies/oa-license-policy/elsevier-user-license |
dc.subject | Ossos -- Càncer |
dc.subject | Cervell -- Tumors |
dc.subject | Regulació genètica |
dc.title | Expression of endoplasmic reticulum stress proteins is a candidate marker of brain metastasis in both ErbB-2+ and ErbB-2- primary breast tumors |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract | |
dc.description.abstract |